Evidence map›Paper›PMID 33969276›Full record

ArticleHemaSphere2021

Acquisition of

Florence Nguyen-Khac, Simon Bouzy, Damien Roos-Weil, Clotilde Bravetti, Agathe Maillon, M'boyba Diop, Cécile Doualle, Nathalie Droin, Olivier A Bernard, Elise Chapiro

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in HemaSphere, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Florence Nguyen-KhacService d'Hématologie Biologique, Hôpital Pitié-Salpêtrière, Assistance Publique-Hopitaux de Paris, France.
Simon BouzyService d'Hématologie Biologique, Centre Hospitalo-Universitaire de Rennes, France.
Damien Roos-WeilSorbonne Université, Centre de Recherche des Cordeliers, Inserm, Université de Paris, Cell Death and Drug Resistance in Lymphoproliferative Disorders Team, Paris, France.
Clotilde BravettiService d'Hématologie Biologique, Hôpital Pitié-Salpêtrière, Assistance Publique-Hopitaux de Paris, France.
Agathe MaillonService d'Hématologie Biologique, Hôpital Pitié-Salpêtrière, Assistance Publique-Hopitaux de Paris, France.
M'boyba DiopAnalyse moléculaire, modélisation et imagerie de la maladie cancéreuse, INSERM US23/Centre National de la Recherche Scientifique UMS3655, Gustave Roussy, Villejuif, France.
Cécile DoualleSorbonne Université, Centre de Recherche des Cordeliers, Inserm, Université de Paris, Cell Death and Drug Resistance in Lymphoproliferative Disorders Team, Paris, France.
Nathalie DroinAnalyse moléculaire, modélisation et imagerie de la maladie cancéreuse, INSERM US23/Centre National de la Recherche Scientifique UMS3655, Gustave Roussy, Villejuif, France.
Olivier A BernardINSERM, U1170, Institut Gustave Roussy, Villejuif, France.
Elise ChapiroService d'Hématologie Biologique, Hôpital Pitié-Salpêtrière, Assistance Publique-Hopitaux de Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33969276
PMCPMC8096467

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.